Arvinas Inc reports results for the quarter ended in March - Earnings Summary

Arvinas

07/05/2024 19:11

* Arvinas Inc  ARVN.OQ  reported a quarterly adjusted loss
of 97
cents​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of
$-1.54.  The mean expectation of nineteen analysts for the
quarter was for a loss of $1.41 per share. Wall Street expected
results to range from $-2.42 to -95 cents per share.
    * Revenue fell 22.2% to $25.30 million from a year ago;
analysts
expected $34.84 million. 
    * Arvinas Inc's reported EPS for the quarter was a loss
of 97
cents​.
    * The company reported a quarterly loss of $69.4 million.
    * Arvinas Inc shares had fallen by 21.9% this quarter and
lost 21.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 11.1%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 18 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Arvinas Inc is
$68.50 
This summary was machine generated from LSEG data May 7 at 06:11
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -1.41          -0.97          Beat
 Dec. 31 2023      -1.27          -2.53          Missed
 Sep. 30 2023      -1.58          -1.18          Beat
 Jun. 30 2023      -1.65          -1.25          Beat